Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,090,383    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,029,233      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,755 Incyte Corp $916,566 Immunome Inc. $146,148 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,755 Incyte Corp $916,566 Immunome Inc. $146,148 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -11.5%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 15 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-10-14 4 AS $89.89 $359,560 D/D (4,000) 324,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-01-13 4 AS $112.25 $1,122,500 D/D (10,000) 320,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-01-17 4 AS $111.55 $1,115,500 D/D (10,000) 320,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-10 4 AS $110.11 $1,651,650 D/D (15,000) 320,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-13 4 AS $109.15 $654,900 D/D (6,000) 320,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-10 4 AS $92.28 $1,384,200 D/D (15,000) 487,856 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-13 4 AS $90.45 $723,600 D/D (8,000) 487,856 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-04-06 4 AS $96.13 $961,300 D/D (10,000) 425,896 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-04-10 4 AS $99.56 $995,600 D/D (10,000) 425,896 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-09 4 AS $94.22 $2,847,973 D/D (30,000) 426,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-10 4 AS $94.65 $2,845,397 D/D (30,000) 426,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-11 4 AS $94.55 $2,840,226 D/D (30,000) 426,213 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2023-12-21 4 AS $93.99 $939,900 D/D (10,000) 425,112 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-01-09 4 AS $98.19 $981,900 D/D (10,000) 425,162 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-01-10 4 AS $96.38 $963,800 D/D (10,000) 425,162 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-02-08 4 AS $89.77 $1,346,550 D/D (15,000) 419,602 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-02-09 4 AS $88.28 $1,324,200 D/D (15,000) 419,602 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-11 4 AS $90.99 $1,819,800 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-12 4 AS $91.26 $1,825,200 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-09 4 AS $81.62 $1,632,400 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-10 4 AS $81.14 $1,622,800 D/D (20,000) 474,994 0 -
IMUX Immunic Inc Director   –       •      –    2001-04-23 4 B $12.00 $99,996 D/D 8,333 8,333 2.39 -
BMRN Biomarin Pharmaceutical I... officerTitle   •       •      –    2005-12-12 4 B $10.21 $10,208 D/D 1,000 11,000 2.81 -
BMRN Biomarin Pharmaceutical I... officerTitle   •       •      –    2006-01-03 4 B $10.76 $16,190 D/D 1,500 12,500 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2006-05-08 4 B $12.78 $12,778 D/D 1,000 22,881 2.81 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15  16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 15 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us